Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

WRIGHT MEDICAL FRANCE : revenue, balance sheet and financial ratios

WRIGHT MEDICAL FRANCE is a French company founded 36 years ago, specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques. Based in PARIS (75017), this company of category PME shows in 2020 a net income positive of 972€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - WRIGHT MEDICAL FRANCE (SIREN 353113442)
Indicator 2020 2019 2018 2017 2016
Revenue N/C N/C N/C N/C N/C
Net income 972 € -25 977 € 111 884 € 67 609 € 33 253 €
EBITDA -2 621 € -16 831 € 84 654 € -1 541 633 € -1 516 245 €
Net margin N/C N/C N/C N/C N/C

Revenue and income statement

In 2020, WRIGHT MEDICAL FRANCE generates positive net income of 972 €. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2020: 33 k€ -> 972 €.

EBITDA (2020) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

-2 621 €

EBIT (2020) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

1 350 €

Net income (2020) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

972 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 11%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 90%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 177.3 years of cash flow to repay all financial debt. Beyond 7 years, banks generally consider credit risk as high.

Debt ratio (2020) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

11.348%

Financial autonomy (2020) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

89.809%

Repayment capacity (2020) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

177.314

Solvency indicators evolution
WRIGHT MEDICAL FRANCE

Sector positioning

Debt ratio
11.35 2020
2018
2019
2020
Q1: 0.0
Med: 9.34
Q3: 68.4
Average

In 2020, the debt ratio of WRIGHT MEDICAL FRANCE (11.35) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
89.81% 2020
2018
2019
2020
Q1: 14.08%
Med: 36.68%
Q3: 58.19%
Excellent

In 2020, the financial autonomy of WRIGHT MEDICAL FRANCE (89.8%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Repayment capacity
177.31 years 2020
2018
2019
2020
Q1: 0.0 years
Med: 0.01 years
Q3: 1.74 years
Watch +10 pts over 3 years

In 2020, the repayment capacity of WRIGHT MEDICAL FRANCE (177.31) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2020) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2020) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2020) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2020) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
WRIGHT MEDICAL FRANCE

Positioning of WRIGHT MEDICAL FRANCE in its sector

Comparison with sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Valuation estimate

Based on 124 transactions of similar company sales (all years), the value of WRIGHT MEDICAL FRANCE is estimated at 798 € (range 303€ - 2 916€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2020
124 transactions
0k€ 0k€ 2k€
798 € Range: 303€ - 2 916€
NAF 5 all-time

Valuation method used

Net Income Multiple
972 € × 0.8x = 799 €
Range: 304€ - 2 916€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 124 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de gros (commerce interentreprises) de produits pharmaceutiques)

Compare WRIGHT MEDICAL FRANCE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Frequently asked questions about WRIGHT MEDICAL FRANCE

What is the revenue of WRIGHT MEDICAL FRANCE ?

The revenue of WRIGHT MEDICAL FRANCE is not publicly disclosed (confidential accounts filed with INPI).

Is WRIGHT MEDICAL FRANCE profitable?

Yes, WRIGHT MEDICAL FRANCE generated a net profit of 972€ in 2020.

Where is the headquarters of WRIGHT MEDICAL FRANCE ?

The headquarters of WRIGHT MEDICAL FRANCE is located in PARIS (75017), in the department Paris.

Where to find the tax return of WRIGHT MEDICAL FRANCE ?

The tax return of WRIGHT MEDICAL FRANCE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does WRIGHT MEDICAL FRANCE operate?

WRIGHT MEDICAL FRANCE operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.